← Back
$TERN All transactions

Terns Pharmaceuticals, Inc.

▼ SELL 10b5-1 Plan

$ Value

$2.3M

Shares

61,228

Price

$37

Filed

Jan 16

Insider

Name

Burroughs Amy L.

Title

Chief Executive Officer

CIK

0001872564

Roles

Director Officer

Transaction Details

Transaction Date

2026-01-15

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

296,497

Footnotes

Each share is represented by a Restricted Stock Unit ("RSU"). 25% of the RSUs vest on the first anniversary measured from January 1, 2026 (the "Vesting Commencement Date"), and 1/16th of the total number of shares vest quarterly thereafter, such that 100% of the RSUs will be fully vested on the fourth anniversary of the Vesting Commencement Date. | The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 30, 2025. | This sale price represents the weighted average sale price of the shares sold ranging from $36.45 to $37.445 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote | This sale price represents the weighted average sale price of the shares sold ranging from $37.45 to $37.75 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote | The Reporting Person beneficially owns these shares indirectly through the Amy L Burroughs 2017 Trust. | 25% of the shares subject to the option vest on the first anniversary measured from January 1, 2026 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date. | 25% of the shares subject to the option vest on the first anniversary measured from January 1, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.

Filing Info

Accession No.

0001872564-26-000004

Form Type

4

Issuer CIK

0001831363

Burroughs Amy L.'s History

Date Ticker Type Value
2026-02-17 TERN M $68K
2026-02-17 TERN $89K
2026-02-17 TERN $320K
2026-02-17 TERN $163K
2026-02-17 TERN M $0
2026-01-15 TERN M $126K
2026-01-15 TERN M $126K
2026-01-15 TERN M $68K
2026-01-15 TERN $2.3M
2026-01-15 TERN $282K

Other Insiders at TERN (90d)

Insider Bought Sold Last
FELLOWS DAVID A 2026-02-01
KINDLER JEFFREY B 2026-02-01
Turner Heather D 2026-02-01
Azelby Robert 2026-02-01
Tripuraneni Radhika 2026-02-01
Quigley Jill M. 2026-02-01
Burroughs Amy L.
Chief Executive Officer
$572K 2026-02-17
Kuriakose Emil
Chief Medical Officer
$50K 2026-04-01